Hosangadi D, Smith PG, Giersing BK (2017) Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy. Vaccine. https://doi.org/10.1016/j.vaccine.2017.09.083. (PubMed PMID: 29031690)

Article  PubMed  Google Scholar 

Porter CK, Olson S, Hall A, Riddle MS (2017) Travelers’ diarrhea: an update on the incidence, etiology, and risk in military deployments and similar travel populations. Mil Med 182(S2):4–10. https://doi.org/10.7205/MILMED-D-17-00064. (PubMed PMID: 28885918)

Article  PubMed  Google Scholar 

Steffen R, Hill DR, DuPont HL (2015) Traveler’s diarrhea: a clinical review. JAMA 313(1):71–80. https://doi.org/10.1001/jama.2014.17006. (PubMed PMID: 25562268)

Article  PubMed  CAS  Google Scholar 

Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM (2007) Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun 75(8):3961–3968

Article  PubMed  PubMed Central  CAS  Google Scholar 

Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A et al (2015) Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health 3(9):e564–e575. https://doi.org/10.1016/S2214-109X(15)00151-5. (PubMed PMID: 26202075)

Article  PubMed  PubMed Central  Google Scholar 

Levine MM, Nasrin D, Acacio S, Bassat Q, Powell H, Tennant SM et al (2020) Diarrhoeal disease and subsequent risk of death in infants and children residing in low-income and middle-income countries: analysis of the GEMS case-control study and 12-month GEMS-1A follow-on study. Lancet Glob Health. https://doi.org/10.1016/S2214-109X(19)30541-8

Article  PubMed  Google Scholar 

Isidean SD, Riddle MS, Savarino SJ, Porter CK (2011) A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. Vaccine 29(37):6167–6178. https://doi.org/10.1016/j.vaccine.2011.06.084. (PubMed PMID: 21723899)

Article  PubMed  CAS  Google Scholar 

Gupta SK, Keck J, Ram PK, Crump JA, Miller MA, Mintz ED (2008) Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries 1984–2005. Epidemiol Infect 136(6):721–738. https://doi.org/10.1017/S095026880700934X

Article  PubMed  CAS  Google Scholar 

Rivera FP, Ochoa TJ, Maves RC, Bernal M, Medina AM, Meza R et al (2010) Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from Peruvian children. J Clin Microbio 48(9):3198–3203. https://doi.org/10.1128/JCM.00644-10

Article  CAS  Google Scholar 

Carpenter CM, Hall ER, Randall R, McKenzie R, Cassels F, Diaz N et al (2006) Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers. Vaccine 24(18):3709–3718

Article  PubMed  CAS  Google Scholar 

Cruz JR, Gil L, Cano F, Caceres P, Pareja G (1988) Breast milk anti-Escherichia coli heat-labile toxin IgA antibodies protect against toxin-induced infantile diarrhea. Acta Paediatr Scand 77(5):658–662 (PubMed PMID: 3059753)

Article  PubMed  CAS  Google Scholar 

Porter CK, Riddle MS, Tribble DR, Louis Bougeois A, McKenzie R, Isidean SD, et al. A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC). Vaccine. 2011.

Wenneras C, Erling V (2004) Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world. J Health Popul Nutr 22(4):370–382 (Epub 2005/01/25 PubMed PMID: 15663170)

PubMed  Google Scholar 

Svennerholm AM (2011) From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res 133(2):188–196

PubMed  PubMed Central  CAS  Google Scholar 

Svennerholm AM, Holmgren J, Black R, Levine M, Merson M (1983) Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J Infect Dis 147(3):514–522 (Epub 1983/03/01 PubMed PMID: 6339647)

Article  PubMed  CAS  Google Scholar 

Norton EB, Branco LM, Clements JD (2015) Evaluating the a-subunit of the heat-labile toxin (LT) As an immunogen and a protective antigen against enterotoxigenic Escherichia coli (ETEC). PLoS ONE 10(8):e0136302. https://doi.org/10.1371/journal.pone.0136302.PubMedPMID:26305793;PubMedCentralPMCID:PMCPMC4549283

Article  PubMed  PubMed Central  Google Scholar 

Finkelstein RA, Burks MF, Zupan A, Dallas WS, Jacob CO, Ludwig DS (1987) Epitopes of the cholera family of enterotoxins. Rev Infect Dis 9(3):544–561 (Epub 1987/05/01 PubMed PMID: 2440089)

Article  PubMed  CAS  Google Scholar 

Holmes RK, Twiddy EM (1983) Characterization of monoclonal antibodies that react with unique and cross-reacting determinants of cholera enterotoxin and its subunits. Infect Immun 42(3):914–923

Article  PubMed  PubMed Central  CAS  Google Scholar 

Remmers EF, Colwell RR, Goldsby RA (1982) Production and characterization of monoclonal antibodies to cholera toxin. Infect Immun 37(1):70–76

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lindholm L, Holmgren J, Wikstrom M, Karlsson U, Andersson K, Lycke N (1983) Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin. Infect Immun 40(2):570–576

Article  PubMed  PubMed Central  CAS  Google Scholar 

Peterson JW, Hejtmancik KE, Markel DE, Craig JP, Kurosky A (1979) Antigenic specificity of neutralizing antibody to cholera toxin. Infect Immun 24(3):774–779

Article  PubMed  PubMed Central  CAS  Google Scholar 

Clements JD, Hartzog NM, Lyon FL (1988) Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 6(3):269–277

Article  PubMed  CAS  Google Scholar 

Dickinson BL, Clements JD (1995) Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 63(5):1617–1623

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guidry JJ, Cardenas L, Cheng E, Clements JD (1997) Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin. Infect Immun 65(12):4943–4950

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tida Lee RLG, Maciel M, Poole S, Testa KJ, Trop S, Duplessis C, Lane A, Riddle MS, Hamer M, Alcala A, Prouty M, Maier N, Rahsan Erdem A, Bourgeois L, Portera CK (2021) Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli. Vaccine. https://doi.org/10.1016/j.vaccine.2021.08.032

Article  PubMed  PubMed Central  Google Scholar 

Lycke N, Tsuji T, Holmgren J (1992) The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol 22(9):2277–2281. https://doi.org/10.1002/eji.1830220915

Article  PubMed  CAS  Google Scholar 

Cheng E, Cardenas-Freytag L, Clements JD (1999) The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT). Vaccine 18(1–2):38–49 (Epub 1999/09/29 PubMed PMID: 10501233)

Article  PubMed  CAS  Google Scholar 

Clements JD, Norton EB (2018) The mucosal vaccine adjuvant LT(R192G/L211A) or dmLT. Sphere. https://doi.org/10.1128/mSphere.00215-18

Article  Google Scholar 

Norton EB, Lawson LB, Freytag LC, Clements JD (2011) Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant. Clin Vaccine Immunol 18(4):546–551

Article  PubMed  PubMed Central  CAS